etiology of neurodegenerative diseases and that we advance the field of gene therapy by providing new and innovative technologies. " Professional Background Since 2013 Member of Munich Cluster for Systems Neurology, SyNergy Since 2009 Partner of the DZNE (Deutsches Zentrum für Neurodegenerative…
more
farms between the age of 2 and 12 months who took part in PASTURE – a European birth cohort, which runs for almost 20 years now with funding from the European Commission. “We found that a comparatively large part of the protective farm effect on childhood asthma was mediated by the maturation of the…
more
mechanisms” in 2013 and the foundation of HI-MAG in 2018. In December 2019, Matthias became Director of the Helmholtz Institute for Metabolic, Obesity and Vascular Research and W3 Professor for Clinical Obesity Research at the University of Leipzig. Research Areas and Expertise Treatment of people…
more
Intermittent fasting to improve insulin secretion: The IFIS study investigates the effect of intermittent fasting on insulin secretion. View clinical trial Exercise Study (acEX) The acEX study investigates the effects of acute exercise on insulin response in the brain. View clinical trial Research…
more
the genetics of diabetes and obesity, neuroendocrine control of appetite and adipose tissue as a secretory organ and recently the role of the microbiome in diabetes and obesity Important Career Steps since 2019 Clinical Programme Director of the Helmholtz Institute for Metabolic, Obesity and…
more
to the Department of Biomedical Engineering at the University of California, Davis as a postdoctoral research employee. Since 2016, he is leading the Fluorescence Imaging group at the Chair of Biological Imaging and Center for Translational Cancer Research (TranslaTUM) of the Technical University of…
more
autoimmunity. We showed that autoimmunity develops most frequently around 1 to 2 years of age and that the proinsulin prohormone is a primary target antigen in this age period. Lab Regina Feederle, IDO The Monoclonal Antibody Core Facillity The Monoclonal Antibody Core Facillity at the Helmholtz Zen…
more
promoted at Helmholtz Munich. A team of experts advises researchers on patent applications as well as on cooperation with industry and the spin-off of high-tech companies. Innovations and transfer are specifically promoted at Helmholtz Munich. A team of experts advises researchers on patent…
more
http://www.tud/de/cmcb About Helmholtz Munich Helmholtz Munich is a leading biomedical research center. Its mission is to develop breakthrough solutions for better health in a rapidly changing world. Interdisciplinary research teams focus on environmentally triggered diseases, especially the therapy…
more
million people, with rising incidence rates over the past decades, this syndrome is a major threat for public health and society globally. However, existing studies do not sufficiently describe the molecular changes of pancreatic islet beta cells leading to their deficient insulin secretion. Now, an…
more